Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Annuities

New York Fines Insurer

By Allison Bell

X
Your article was successfully shared with the contacts you provided.

Empire State regulators have imposed a $1.9 million fine on a financial services company in connection with allegations of annuity replacement disclosure violations and other violations.

AXA Equitable Life Insurance Company, New York, a unit of AXA S.A., Paris, paid the fine to the New York State Insurance Department, department officials say.

The department announcement “relates to a standard examination, begun 4 years ago, which found no consumer harm,” an AXA Equitable spokesman says. “We’re pleased to put it behind us.”

Department officials discovered evidence of the alleged violations, which officials say occurred from Jan. 1, 2001, to June 30, 2006, during a routine examination, officials say.

The department received no complaints about AXA Equitable during that period, officials say.

In New York, Regulation 60 requires companies to give consumers disclosure statements in cases when sales of new policies will cause buyers to surrender, lapse, or in any way change the status of existing policies.

Insurers must give insureds complete and accurate comparative information about significant features of the replaced and replacing policies or annuity contracts, officials say.

From Jan. 1, 2001, through Dec. 31, 2005, AXA Equitable also used an unapproved policy form; failing to give policyholders required information concerning accelerated benefit claims; failed to obtain written informed consent prior to subjecting applicants to HIV-related testing; and failed to maintain some variable annuity claim documentation, officials say.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.